Patents by Inventor Sandra J. Rattray

Sandra J. Rattray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Toxoplasma gondii cylclic GMP dependent protein kinase G as a chemotherapeutic target for antiprotozoal agents
    Patent number: 7718390
    Abstract: Protozoal cyclic GMP dependent protein kinases have been isolated and cloned. These enzymes may be used in screening assays to identify potential antiprotozoal agents.
    Type: Grant
    Filed: September 21, 2006
    Date of Patent: May 18, 2010
    Assignee: Merial Limited
    Inventors: Anne Gurnett, Robert Donald, Georgianna Harris, Paul A. Liberator, Dennis Schmatz, Sandra J. Rattray
  • Cyclic GMP dependent protein kinase as a chemotherapeutic target for antiprotozoal agents
    Patent number: 7125700
    Abstract: Protozoal cyclic GMP dependent protein kinases have been isolated and cloned. These enzymes may be used in screening assays to identify potential antiprotozoal agents.
    Type: Grant
    Filed: January 21, 2003
    Date of Patent: October 24, 2006
    Assignee: Merck & Co., Inc.
    Inventors: Anne Gurnett, Robert Donald, Georgianna Harris, Paul A. Liberator, Dennis Schmatz, Sandra J. Rattray
  • Cyclic GMP dependent protien kinase as a chemotherapeutic target for antiprotozoal agents
    Publication number: 20030211552
    Abstract: Protozoal cyclic GMP dependent protein kinases have been isolated and cloned. These enzymes may be used in screening assays to identify potential antiprotozoal agents.
    Type: Application
    Filed: January 21, 2003
    Publication date: November 13, 2003
    Inventors: Anne Gurnett, Robert Donald, Georgianna Harris, Paul A. Liberator, Dennis Schmatz, Sandra J. Rattray
  • Polynucleotide encoding eimeria tenella cGMP dependent protein kinase
    Patent number: 6555358
    Abstract: Protozoal cyclic GMP dependent protein kinases have been isolated and cloned. These enzymes may be used in screening assays to identify potential antiprotozoal agents.
    Type: Grant
    Filed: March 8, 2000
    Date of Patent: April 29, 2003
    Assignee: Merck & Co., Inc.
    Inventors: Anne Gurnett, Paul A. Liberator, Robert Donald, Dennis Schmatz, Georgianna Harris, Sandra J. Rattray
  • Apicidin-derived cyclic tetrapeptides
    Publication number: 20030078369
    Abstract: Cyclic tetrapeptide compounds derived from apicidin therapeutically inhibit histone deacetylase activity, are represented by Formula I: 1
    Type: Application
    Filed: January 31, 2002
    Publication date: April 24, 2003
    Inventors: Peter T. Meinke, Dennis Schmatz, Robert W. Myers, Sandra J. Rattray, Steven L. Colletti, Matthew J. Wyvratt, Michael H. Fisher, Anne M. Gurnett
  • Histone deacetylase as target for antiprotozoal agents
    Patent number: 6428983
    Abstract: Histone deacetylase inhibition provides a target for identifying potential antiprotozoal compounds. Histone deacetylase inhibitors are useful as therapeutic agents against protozoal infections.
    Type: Grant
    Filed: April 22, 1999
    Date of Patent: August 6, 2002
    Assignee: Merck & Co.
    Inventors: Paula M. Dulski, Robert W. Myers, Anne M. Gumett, Sandra J. Rattray, Dennis M. Schmatz
  • Histone deacetylase as target for antiprotozoal agents
    Patent number: 6110697
    Abstract: Histone deacetylase inhibition provides a target for identifying potential antiprotozoal compounds. Histone deacetylase inhibitors are useful as therapeutic agents against protozoal infections.
    Type: Grant
    Filed: September 20, 1996
    Date of Patent: August 29, 2000
    Assignee: Merck & Co., Inc.
    Inventors: Paula M. Dulski, Robert W. Myers, Anne M. Gumett, Sandra J. Rattray, Dennis M. Schmatz
  • Histone deacetylase as target for antiprotozoal agents
    Patent number: 6068987
    Abstract: Histone deacetylase inhibition provides a target for identifying potential antiprotozoal compounds. Histone deacetylase inhibitors are useful as therapeutic agents against protozoal infections.
    Type: Grant
    Filed: November 18, 1999
    Date of Patent: May 30, 2000
    Assignee: Merck & Co., Inc.
    Inventors: Paula M. Dulski, Robert W. Myers, Anne M. Gurnett, Sandra J. Rattray, Dennis M. Schmatz
  • Antiprotozoal cyclic tetrapeptides
    Patent number: 5922837
    Abstract: The present invention provides novel cyclic tetrapeptides useful in the treatment or prevention of protozoal diseases; in particular, the novel compounds are active against the causative pathogens in malaria, toxoplasmosis, and coccidiosis. The invention also relates to the use of known compounds which are histone deacetylase inhibitors as antiprotozoal agents.
    Type: Grant
    Filed: January 27, 1997
    Date of Patent: July 13, 1999
    Assignee: Merck & Co., Inc.
    Inventors: Peter T. Meinke, Sandra J. Rattray, Dennis M. Schmatz
  • Antiprotozoal cyclic tetrapeptides
    Patent number: 5861375
    Abstract: The present invention provides novel cyclic tetrapeptides useful in the treatment or prevention of protozoal diseases; in particular, the novel compounds are active against the causative pathogens in malaria, toxoplasmosis, and coccidiosis.
    Type: Grant
    Filed: January 28, 1997
    Date of Patent: January 19, 1999
    Assignee: Merck & Co., Inc.
    Inventors: Christine Lange Cannova, Anne W. Dombrowski, Michael A. Goetz, Sandra J. Rattray, Sheo Bux Singh, Jon Polishook, Gerald F. Bills, Joyce A. Greene, Gary K. Darland
  • Antiprotozoal cyclic tetrapeptides
    Patent number: 5620953
    Abstract: The present invention provides novel cyclic tetrapeptides useful in the treatment or prevention of protozoal diseases; in particular, the novel compounds are active against the causative pathogens in malaria, toxoplasmosis, and coccidiosis.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: April 15, 1997
    Assignee: Merck & Co., Inc.
    Inventors: Christine L. Cannova, Michael A. Goetz, Anne W. Dombrowski, Sandra J. Rattray, Sheo B. Singh, Gerald F. Bills, Jon Polishook, Joyce A. Greene, Gary K. Darland